BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4818375)

  • 61. Altered activity of hepatic mixed-function mono-oxygenase enzymes in streptozotocin-induced diabetic rats.
    Reinke LA; Stohs SJ; Rosenberg H
    Xenobiotica; 1978 Oct; 8(10):611-9. PubMed ID: 152519
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lack of effect of vasectomy on hepatic mixed function monooxygenase enzymes in the rat.
    Reinke LA; Stohs SJ
    Contraception; 1977 May; 15(5):535-42. PubMed ID: 880824
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Components of the heme biosynthetic pathway and mixed function oxidase activity in human fetal tissues.
    Rifkind AB; Bennett S; Forster ES; New MI
    Biochem Pharmacol; 1975 Apr; 24(8):839-46. PubMed ID: 1125083
    [No Abstract]   [Full Text] [Related]  

  • 64. Ethionine-induced alterations in hepatic microsomal cytochromes in vivo and in vitro: sexual dimorphism.
    Chen WJ; Smuckler EA
    Toxicol Appl Pharmacol; 1978 May; 44(2):269-76. PubMed ID: 27882
    [No Abstract]   [Full Text] [Related]  

  • 65. The B-vitamin group and the activity of hepatic microsomal mixed-function oxidases of the growing Wistar rat.
    Miltenberger R; Oltersdorf U
    Br J Nutr; 1978 Jan; 39(1):127-37. PubMed ID: 619964
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of hepatic microsomal monooxygenase activity by oxine-5-sulfonic acid administered orally in rabbits.
    Gregotti C; Rugarli PL; Di Nucci A; Richelmi P; Manzo L; Bertè F
    Farmaco Prat; 1979 Nov; 34(11):474-7. PubMed ID: 116869
    [No Abstract]   [Full Text] [Related]  

  • 67. Demonstration of drug-ethanol interactions by changes in activity of hepatic microsomal oxidase/oxygenase cytochrome P-450 function.
    Heinemeyer G; Hildebrandt AG; Roots I; Lehne L; Nigam S
    Arch Toxicol Suppl; 1979; (2):491-6. PubMed ID: 288365
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Microsomal drug-metabolizing enzyme activity in rats given alpha-(2,4-dichlorophenyl)-alpha-phenyl-5-pyrimidinemethanol for period of 14 days to 2 years.
    Hoffman DG; Bernhard NR; Worth HM; Emmerson JL
    Toxicol Appl Pharmacol; 1976 Mar; 35(3):413-21. PubMed ID: 178071
    [No Abstract]   [Full Text] [Related]  

  • 69. Dichloro-P-nitroanisole O-demethylase--a convenient assay for microsomal mixed function oxidase in isolated rat hepatocytes.
    Hultmark D; Sundh K; Wachtmeister CA; Arrhenius E
    Biochem Pharmacol; 1978; 27(8):1129-34. PubMed ID: 29645
    [No Abstract]   [Full Text] [Related]  

  • 70. Characteristics and differences in the hepatic mixed function oxidases of different species.
    Kato R
    Pharmacol Ther; 1979; 6(1):41-98. PubMed ID: 390561
    [No Abstract]   [Full Text] [Related]  

  • 71. Changes in the mixed function oxidase enzymes as a result of individual amino acid deficiencies.
    Truex CR; Brattsten L; Visek WJ
    Biochem Pharmacol; 1977 Apr; 26(7):667-70. PubMed ID: 856198
    [No Abstract]   [Full Text] [Related]  

  • 72. Hepatic microsomal enzymes and their alterations in pathologic conditions.
    Denk H
    Prog Liver Dis; 1979; 6():263-83. PubMed ID: 396559
    [No Abstract]   [Full Text] [Related]  

  • 73. Effect of ethylenebisdiisothiocyanato sulfide (EBIS) on hepatic monooxygenase activity.
    Yoshida T; Jordan L; Neal RA
    Toxicol Appl Pharmacol; 1978 Oct; 46(1):215-25. PubMed ID: 725944
    [No Abstract]   [Full Text] [Related]  

  • 74. Effects of non-gonadal hormones on rat liver drug-metabolizing enzymes and cytochrome P-450 during early postnatal development [proceedings].
    Leakey JE; Fouts JR; Dutton GJ
    Biochem Soc Trans; 1979 Oct; 7(5):1103-4. PubMed ID: 510715
    [No Abstract]   [Full Text] [Related]  

  • 75. Inhibitors of hepatic mixed function oxidases--II. Some benzimidazole, benzoxazole and benzothiazole derivatives.
    Holder GM; Little PJ; Ryan AJ; Watson TR
    Biochem Pharmacol; 1976 Dec; 25(24):2747-50. PubMed ID: 1008898
    [No Abstract]   [Full Text] [Related]  

  • 76. Alterations in hepatic heme biosynthetic capability and mixed function oxidase activity during ethionine exposure in rats.
    Woods JS
    Mol Pharmacol; 1978 Sep; 14(5):900-10. PubMed ID: 714028
    [No Abstract]   [Full Text] [Related]  

  • 77. Differential action of progesterones on hepatic microsomal activities in the rat.
    Feuer G; Kardish R; Farkas R
    Biochem Pharmacol; 1977 Aug; 26(16):1495-9. PubMed ID: 197967
    [No Abstract]   [Full Text] [Related]  

  • 78. Mutagenic and alkylating metabolites of halo-ethylenes, chlorobutadienes and dichlorobutenes produced by rodent or human liver tissues. Evidence for oxirane formation by P450-linked microsomal mono-oxygenases.
    Bartsch H; Malaveille C; Barbin A; Planche G
    Arch Toxicol; 1979 Feb; 41(4):249-77. PubMed ID: 373707
    [No Abstract]   [Full Text] [Related]  

  • 79. Critical parameters for the determination of aminopyrine demethylase (ADP) activity, as assayed in hepatic microsomes from mice and rats [proceedings].
    Bauer C; Cercignani G; Gervasi PG; Stretti G; Turchi G; Di Natale G
    Ital J Biochem; 1976; 25(5):423-4. PubMed ID: 139385
    [No Abstract]   [Full Text] [Related]  

  • 80. [Application of immobilized animal liver microsomal fraction to the reaction of 1,4-benzdiazepine-2-one conversion].
    Bogatskiĭ AV; Davidenko TI; Sevast'ianov OV
    Ukr Biokhim Zh (1978); 1979; 51(4):382-6. PubMed ID: 473387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.